chr17-46030147-GT-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_015443.4(KANSL1):c.*1328delA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 141,984 control chromosomes in the GnomAD database, including 2,078 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.15 ( 2078 hom., cov: 27)
Exomes 𝑓: 0.091 ( 0 hom. )
Consequence
KANSL1
NM_015443.4 3_prime_UTR
NM_015443.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.103
Genes affected
KANSL1 (HGNC:24565): (KAT8 regulatory NSL complex subunit 1) This gene encodes a nuclear protein that is a subunit of two protein complexes involved with histone acetylation, the MLL1 complex and the NSL1 complex. The encoded protein has been implicated in a variety of cellular processes including enhancer regulation, cell proliferation, and mitosis. Mutations in this gene are associated with Koolen-de Vries Syndrome. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 17-46030147-GT-G is Benign according to our data. Variant chr17-46030147-GT-G is described in ClinVar as [Benign]. Clinvar id is 323738.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KANSL1 | NM_015443.4 | c.*1328delA | 3_prime_UTR_variant | 15/15 | ENST00000432791.7 | NP_056258.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.151 AC: 21418AN: 141490Hom.: 2080 Cov.: 27
GnomAD3 genomes
AF:
AC:
21418
AN:
141490
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0907 AC: 37AN: 408Hom.: 0 Cov.: 0 AF XY: 0.0854 AC XY: 21AN XY: 246
GnomAD4 exome
AF:
AC:
37
AN:
408
Hom.:
Cov.:
0
AF XY:
AC XY:
21
AN XY:
246
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.151 AC: 21408AN: 141576Hom.: 2078 Cov.: 27 AF XY: 0.142 AC XY: 9758AN XY: 68574
GnomAD4 genome
AF:
AC:
21408
AN:
141576
Hom.:
Cov.:
27
AF XY:
AC XY:
9758
AN XY:
68574
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Syndromic intellectual disability Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
MAPT-Related Spectrum Disorders Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at